| Patient | Jedi |
|---|---|
| Client | Dana Whitfield |
| Printed | 11/22/2026 |
ALERTS: Stage B2 mitral valve disease. On pimobendan twice daily. Cardiac recheck every six months.
| Species | Dog |
|---|---|
| Breed | Pomchi (Pomeranian x Chihuahua) |
| Color | black and tan |
| Sex | Male neutered |
| Born | 11/22/2018 |
| Age | 8 years |
| Weight | 3.90 kg (8.60 lb) |
| Microchip | 981020000451237 |
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
Brought in for: Coughing at night for about three weeks. Tires on the second half of his walk.
What we think: Myxomatous mitral valve disease, ACVIM stage B2. No congestive failure at this point.
What happens next: Start pimobendan 1.25 mg PO q12h, an hour before food. Owner to count sleeping respiratory rate nightly and call if it stays above 30. Recheck with repeat radiographs in six months, sooner if the cough worsens.
| Medicine | How to give it | Until |
|---|---|---|
| Vetmedin (pimobendan) 1.25 mg |
One tablet · Twice daily · PO One tablet by mouth twice daily, an hour before food. Do not stop without speaking to us. Call if his sleeping breathing rate stays above 30 a minute.
|
ongoing |
Finish the course even if they seem better, unless we tell you otherwise. Telephone us if they will not take it rather than stopping.
Thoracic radiographs, two views abnormal 10/13/2026
Right lateral and DV thorax.
Left atrial enlargement with dorsal displacement of the mainstem bronchi. VHS 11.6 (reference under 10.7). Pulmonary vasculature within normal limits, no interstitial or alveolar pattern. No pleural effusion.
Conclusion: left-sided cardiomegaly consistent with mitral valve disease, no radiographic evidence of congestive heart failure.